Insulin-like growth factor receptor-1 expression predicts postoperative recurrence in adenocarcinoma of the lung.
Explore this paper's citation graph
Summary
The expression status of IGFR1 can be a candidate surrogate marker to select patients who may benefit from adjuvant chemotherapy after a complete resection for adenocarcinoma of the lung.
- Type
- article
- Published
- 2011-07-01
- Cited by
- 14
- References
- 23
- Access
- Open access
- OpenAlex
- https://openalex.org/W1974042164
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23211860
Keywords
Epidermal growth factor receptor, Oncology, Internal medicine, Adenocarcinoma, Lung cancer
References
- Prognostic role of insulin‐like growth factor receptor‐1 expression in small cell lung cancer
- Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF status.
- Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.
- Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
- Insulin‐like growth factor 1 expression correlates with clinical outcome in K‐RAS wild type colorectal cancer patients treated with cetuximab and irinotecan
- Activation of BAD by Therapeutic Inhibition of Epidermal Growth Factor Receptor and Transactivation by Insulin-like Growth Factor Receptor*
- Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.
- The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
- Global Cancer Statistics, 2002
- Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.
- Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K-ras, MET, and Hepatocyte Growth Factor Status
- Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC.
- A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
- TS expression predicts postoperative recurrence in adenocarcinoma of the lung.
- Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
- Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.
- Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.
- High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
- The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
- Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Cited by
- Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
- Comment on ‘Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab’
- Clinical significance of IGF1R expression in non-small-cell lung cancer.
- Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis.
- Epidermal growth factor receptor (EGFR), HER2 and insulin‐like growth factor‐1 receptor (IGF‐1R) status in ovarian adult granulosa cell tumours
- A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
- Prediction of recurrence after complete resection in patients with NSCLC.
- Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer
- The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma.
- Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival
- Prognostic value of IGF-1R in lung cancer
- Effectiveness of Artificial Intelligence Models in Predicting Lung Cancer Recurrence: A Gene Biomarker-Driven Review
- Clinicopathological and Prognostic Significance of the EML 4-ALK Translocation and IGFR 1 , TTF 1 , Napsin A Expression in Patients with Lung Adenocarcinoma
- Retraction Note: Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
Related papers
- Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
- miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.
- Association of cytokines levels with epidermal growth factor receptor mutation in lung cancer patients
- The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
- Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer
- Matrine alters microRNA expression profiles in SGC-7901 human gastric cancer cells
- Study of the expression and function of ACY1 in patients with colorectal cancer.
- MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
- Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population‑based study